270922-33-3

Upstream product

• 224325-01-3 3,4-O-isopropylidene-6-O-tert-butyldiphenylsilyl-β-D-galactopyranosyl 1-carba-2,3,4,6-tetra-O-benzyl-α-D-mannopyranoside 
• 224324-96-3 3,4-O-isopropylidene-6-O-tert-butyldiphenylsilyl-2-deoxy-D-arabino-hex-1-enopyranosyl 1-carba-2,3,4,6-tetra-O-benzyl-α-D-mannopyranoside 
• 138127-49-8 (3aS,6R,6aS)-6-((tert-butyldiphenylsilyloxy)methyl)-2,2-dimethyl-tetrahydrofuro[3,4-d]-[1,3]dioxol-4-ol 
• 58479-61-1 tert-butylchlorodiphenylsilane 

Downstream Products

• 1054636-52-0 3-O-carboxymethyl-β-D-galactopyranosyl 1-carba-2,3,4,6-tetra-O-benzyl-α-D-mannopyranoside 

Relevant academic research and scientific papers

Synthesis of the C-Glycoside Analogue of a Novel Sialyl Lewis X Mimetic

Sialyl Lewis X (sLex) mimetics that can function as selectin antagonists have received considerable attention in connection with the development of novel antiinflammatory therapies. An interesting structure that emerged from the studies of the Wong group is the 1,1-Gal-Man disaccharide 2, reported to bind E-selectin 5 times more strongly than sLex. The C-glycoside derivative 3 is of interest both as a conformational probe for selectin binding and as a hydrolytically stable analogue. Herein we illustrate a novel methodology for β-C-galacto-disaccharides in the synthesis of 3. The protocol has as a key step a novel oxocarbenium ion-enol ether cyclization to give a Cl-substituted galactal.